Mulmit

Q/C TECHNOLOGIES, INC.Q/C TECHNOLOGIES, INC.

QCLS Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2019-12-311,577,033-3,472,103-3,888,249
2018-12-311,665,570-10,060,409-10,849,034
2017-12-313,354,712-6,613,790-7,366,310

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-04-13White Billy Joe50,000
2026-04-13Voss Chelsea Sierra50,000
2026-04-13Silverman JoshuaExecutive Chairman162,162
2026-04-13Silverman JoshuaExecutive Chairman100,000
2026-04-13Glass MitchellChief Medical Officer50,000
2026-04-13Friscia Stephen50,000
2026-04-13Bernstein Bruce50,000
2026-03-30Voss Chelsea Sierra1,753
2026-01-16Voss Chelsea Sierra212,500
2026-01-16Voss Chelsea Sierra25,000
2026-01-16Voss Chelsea Sierra212,500
2025-11-14Glass MitchellDirector, Chief Medical Off.11,420

8-K events

FiledItems
2026-09-11Termination of a material agreement · Officer or director change · Financial statements and exhibits
2026-07-02Termination of a material agreement · Other events
2026-03-13Change in certifying accountant · Financial statements and exhibits
2026-01-23Entry into a material agreement · Officer or director change · Other events · Financial statements and exhibits
2025-12-09Entry into a material agreement · Unregistered sales of equity securities · Other events · Financial statements and exhibits
2025-11-14Officer or director change · Submission of matters to a vote · Financial statements and exhibits
2025-10-06Officer or director change
2025-10-03Entry into a material agreement · Unregistered sales of equity securities · Material modification to rights of security holders · Officer or director change · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

In Vitro & In Vivo Diagnostic Substances — 같은 업종, 그리고 규모가 비슷한 기업In Vitro & In Vivo Diagnostic Substances — and other companies of a similar size

SEC가 같은 업종(In Vitro & In Vivo Diagnostic Substances)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (In Vitro & In Vivo Diagnostic Substances) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.